论文部分内容阅读
源于通过智能手机和“云服务”为患者进行糖尿病检测这一构想,促成了海瑞教授与易特科公司的合作。海瑞·霍氏奥夫(Harry Holthofer)教授是芬兰人,毕业于世界著名的赫尔辛基大学。有着临床免疫学和微生物学双博士学位的他是都柏林城市大学生物分析学首席科学家。20年来,他领导科研团队采用最前沿的细胞/分子生物学、免疫学和生物化学技术,配合先进的显微与生物工程技术,对糖尿病、心血管以及肾脏疾病进行研究。一组数字或许能够说明海瑞在学界取得
The idea of diabetes testing for patients through smartphones and Cloud Services has led Professor Harry to work with E-Techco. Professor Harry Holthofer, a Finnish native, graduated from the world-renowned Helsinki University. He holds a PhD in Clinical Immunology and Microbiology and is the Chief Scientist in Bioanalysis at Dublin City University. For more than 20 years, he has led research teams in cutting-edge cellular / molecular biology, immunology and biochemistry with advanced microscopy and bioengineering to study diabetes, cardiovascular and kidney disease. A set of figures may be able to show that Hairui made in academia